Inventiva S.A. (IVA)
NASDAQ: IVA · Real-Time Price · USD
6.13
+0.08 (1.32%)
Mar 6, 2026, 4:00 PM EST - Market closed
Inventiva Market Cap
Inventiva has a market cap or net worth of $1.15 billion as of March 6, 2026. Its market cap has increased by 300.99% in one year.
Market Cap
1.15B
Enterprise Value
1.16B
1-Year Change
300.99%
Ranking
Category
Stock Price
$6.13
Market Cap Chart
Since October 26, 2018, Inventiva's market cap has increased from $151.00M to $1.15B, an increase of 661.53%. That is a compound annual growth rate of 31.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 1.17B | 32.56% |
| Dec 31, 2025 | 884.84M | 309.83% |
| Dec 31, 2024 | 215.91M | -7.64% |
| Dec 29, 2023 | 233.77M | 16.05% |
| Dec 30, 2022 | 201.44M | -63.07% |
| Dec 31, 2021 | 545.53M | -0.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EyePoint | 1.30B |
| MoonLake Immunotherapeutics | 1.29B |
| AtaiBeckley | 1.29B |
| Septerna | 1.23B |
| Taysha Gene Therapies | 1.23B |
| Bicara Therapeutics | 1.20B |
| DBV Technologies | 1.20B |
| Precigen | 1.19B |